Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Gregory

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The American Journal of Physiology|July 1, 1989
cAMP delays disappearance of gap junctions between pairs of rat hepatocytes in primary cultureJ C Sáez, W A Gregory, T Watanabe, et al.
Journal of Medicinal Chemistry|March 1, 1970
Antiviral agents. I. Bicyclo [2.2.2] octan- and -oct-2-enaminesJ G Whitney, W A Gregory, J C Kauer, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1987
Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721A M Slee, M A Wuonola, R J McRipley, et al.
Journal of Medicinal Chemistry|September 1, 1985
Preparation and antiarthritic and analgesic activity of 4,5-diaryl-2-(substituted thio)-1H-imidazoles and their sulfoxides and sulfonesT R Sharpe, S C Cherkofsky, W E Hewes, et al.
Journal of Medicinal Chemistry|September 1, 1990
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 2. The "A" groupW A Gregory, D R Brittelli, C L Wang, et al.
Journal of Medicinal Chemistry|August 1, 1989
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The "B" groupW A Gregory, D R Brittelli, C L Wang, et al.
Journal of Medicinal Chemistry|March 20, 1992
Antibacterials. synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 4. Multiply-substituted aryl derivativesC H Park, D R Brittelli, C L Wang, et al.
Leukemia|December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone diseaseD C Johnson, N Weinhold, J Mitchell, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The American Journal of Physiology|July 1, 1989
cAMP delays disappearance of gap junctions between pairs of rat hepatocytes in primary cultureJ C Sáez, W A Gregory, T Watanabe, et al.
Journal of Medicinal Chemistry|March 1, 1970
Antiviral agents. I. Bicyclo [2.2.2] octan- and -oct-2-enaminesJ G Whitney, W A Gregory, J C Kauer, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1987
Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721A M Slee, M A Wuonola, R J McRipley, et al.
Journal of Medicinal Chemistry|September 1, 1985
Preparation and antiarthritic and analgesic activity of 4,5-diaryl-2-(substituted thio)-1H-imidazoles and their sulfoxides and sulfonesT R Sharpe, S C Cherkofsky, W E Hewes, et al.
Journal of Medicinal Chemistry|September 1, 1990
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 2. The "A" groupW A Gregory, D R Brittelli, C L Wang, et al.
Journal of Medicinal Chemistry|August 1, 1989
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 1. The "B" groupW A Gregory, D R Brittelli, C L Wang, et al.
Journal of Medicinal Chemistry|March 20, 1992
Antibacterials. synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 4. Multiply-substituted aryl derivativesC H Park, D R Brittelli, C L Wang, et al.
Leukemia|December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone diseaseD C Johnson, N Weinhold, J Mitchell, et al.
Pageof 4